“给药方式”对制药用途权利要求的限定作用分析

发布时间：2018-05-03 06:29

  本文选题：给药方式 + 权利要求　； 参考：《中国新药杂志》2016年15期

【摘要】：本文结合实际案例,探讨了"给药方式"是否对化合物的制药用途产生限定作用这一当前专利审查实践中存在的争议问题。认为对于仅涉及药物使用方法的特征,如果这些特征与制药方法之间不存在直接关系,则对权利要求所请求保护的制药方法不具有限定作用。物质的医药用途权利要求中,给药方式只是医生针对患者选择服用特定药物的行为,与所制备的药物产品中活性成分的含量之间没有直接关系,其不能在制药过程中予以完全体现,因此,仅仅体现在用药过程中的"给药方式"不能使该用途具有新颖性。
[Abstract]:Combining with practical cases, this paper discusses whether the drug administration mode has a limited effect on the pharmaceutical use of compounds, which is a controversial issue in the current patent review practice. It is considered that if there is no direct relationship between these characteristics and pharmaceutical methods for which only drug use methods are involved, there is no limitation on the pharmaceutical methods claimed for protection. In claims for pharmaceutical uses of substances, medication is administered only in a manner that the doctor chooses to take a specific drug for the patient, and there is no direct relationship with the content of the active ingredient in the drug product that is prepared. It can not be fully embodied in the pharmaceutical process, therefore, only reflected in the drug use of the "way" can not make the use of novelty.
【作者单位】： 国家知识产权局专利局专利审查协作天津中心;
【分类号】：R95
，

本文编号：1837399